Impact of factor VIII deficiency on clotting factor utilization in the United States

Louis M. Aledort; Scott H. Goodnight; A. Vuaya Rao; Jan Schwarz; Deborah Whitehurst; Sandor S. Shapiro

doi:10.1007/BF02904743

Impact of factor VIII deficiency on clotting factor utilization in the United States

Louis M. Aledort, Scott H. Goodnight, A. Vuaya Rao, Jan Schwarz, Deborah Whitehurst, Sandor S. Shapiro

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

In a study of 1,551 hemophiliacs over a 4-year period of time, factor VIII utilization was assessed. It is clear that factor VIII usage is a function of severity of disease and therapeutic program. The average amount of factor VIII used per patient was 39.880U/year. Patients seiected for home care, use significantly more than those patients not on home care. As much as 101,000 U/year are used by a small number of patients on prophylaxis. These data can be used in predicting source plasma requirements for annual national use as well as costs.

Original language	English
Pages (from-to)	33-41
Number of pages	9
Journal	La Ricerca in Clinica e in Laboratorio
Volume	13
Issue number	1
DOIs	https://doi.org/10.1007/BF02904743
State	Published - Jan 1983

Keywords

Bleeding
Factor VIII deficiency
Hemophilia
Plasmapheresis

Access to Document

10.1007/BF02904743

Cite this

@article{7e34d25b8f1449b584a6fc0f64e89f5f,

title = "Impact of factor VIII deficiency on clotting factor utilization in the United States",

abstract = "In a study of 1,551 hemophiliacs over a 4-year period of time, factor VIII utilization was assessed. It is clear that factor VIII usage is a function of severity of disease and therapeutic program. The average amount of factor VIII used per patient was 39.880U/year. Patients seiected for home care, use significantly more than those patients not on home care. As much as 101,000 U/year are used by a small number of patients on prophylaxis. These data can be used in predicting source plasma requirements for annual national use as well as costs.",

keywords = "Bleeding, Factor VIII deficiency, Hemophilia, Plasmapheresis",

author = "Aledort, {Louis M.} and Goodnight, {Scott H.} and Rao, {A. Vuaya} and Jan Schwarz and Deborah Whitehurst and Shapiro, {Sandor S.}",

year = "1983",

month = jan,

doi = "10.1007/BF02904743",

language = "English",

volume = "13",

pages = "33--41",

journal = "La Ricerca in Clinica e in Laboratorio",

issn = "0390-5748",

publisher = "Il Ponte",

number = "1",

}

TY - JOUR

T1 - Impact of factor VIII deficiency on clotting factor utilization in the United States

AU - Aledort, Louis M.

AU - Goodnight, Scott H.

AU - Rao, A. Vuaya

AU - Schwarz, Jan

AU - Whitehurst, Deborah

AU - Shapiro, Sandor S.

PY - 1983/1

Y1 - 1983/1

N2 - In a study of 1,551 hemophiliacs over a 4-year period of time, factor VIII utilization was assessed. It is clear that factor VIII usage is a function of severity of disease and therapeutic program. The average amount of factor VIII used per patient was 39.880U/year. Patients seiected for home care, use significantly more than those patients not on home care. As much as 101,000 U/year are used by a small number of patients on prophylaxis. These data can be used in predicting source plasma requirements for annual national use as well as costs.

AB - In a study of 1,551 hemophiliacs over a 4-year period of time, factor VIII utilization was assessed. It is clear that factor VIII usage is a function of severity of disease and therapeutic program. The average amount of factor VIII used per patient was 39.880U/year. Patients seiected for home care, use significantly more than those patients not on home care. As much as 101,000 U/year are used by a small number of patients on prophylaxis. These data can be used in predicting source plasma requirements for annual national use as well as costs.

KW - Bleeding

KW - Factor VIII deficiency

KW - Hemophilia

KW - Plasmapheresis

UR - http://www.scopus.com/inward/record.url?scp=0020670118&partnerID=8YFLogxK

U2 - 10.1007/BF02904743

DO - 10.1007/BF02904743

M3 - Article

C2 - 6407089

AN - SCOPUS:0020670118

SN - 0390-5748

VL - 13

SP - 33

EP - 41

JO - La Ricerca in Clinica e in Laboratorio

JF - La Ricerca in Clinica e in Laboratorio

IS - 1

ER -

Impact of factor VIII deficiency on clotting factor utilization in the United States

Abstract

Keywords

Access to Document

Fingerprint

Cite this